Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dasatinib by Bristol-Myers Squibb for Breast Cancer: Likelihood of Approval
Dasatinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Breast Cancer. According to GlobalData, Phase...